{"id":7982,"date":"2023-08-24T08:14:39","date_gmt":"2023-08-24T06:14:39","guid":{"rendered":"https:\/\/www.dopharma.be\/?p=7982"},"modified":"2024-10-17T11:50:33","modified_gmt":"2024-10-17T09:50:33","slug":"communique-de-presse-melovem-15-mg-ml","status":"publish","type":"post","link":"https:\/\/www.dopharma.be\/fr\/nieuws\/persbericht-melovem-15-mg-ml\/","title":{"rendered":"Communiqu\u00e9 de presse | Introduction Melovem\u00ae 15 mg\/ml"},"content":{"rendered":"<h2>Conditionnement optimal et administration facilit\u00e9e :<\/h2>\n<h2>Melovem<sup>\u00ae<\/sup>\u00a015 mg\/ml suspension buvable pour soulager la douleur chez le cheval<\/h2>\n<p><strong>Raamsdonksveer 24-08-2023<\/strong>\u00a0- Dopharma \u00e9largit sa gamme d'AINS avec Melovem<sup>\u00ae<\/sup>\u00a015 mg\/ml. Cette suspension buvable est enregistr\u00e9e exclusivement pour les chevaux et constitue un ajout bienvenu au c\u00e9l\u00e8bre Melovem<sup>\u00ae<\/sup>\u00a020 mg\/ml injectable (i.v.) de Dopharma pour le traitement des chevaux.<\/p>\n<h4>Soulagement rapide de la douleur gr\u00e2ce \u00e0 l'auto-administration par le propri\u00e9taire du cheval<\/h4>\n<p>Comme pour Melovem<sup>\u00ae<\/sup>\u00a020 mg\/ml, le m\u00e9loxicam est l'ingr\u00e9dient actif de Melovem<sup>\u00ae<\/sup>\u00a015 mg\/ml. La grande diff\u00e9rence et l'avantage est que le propri\u00e9taire du cheval peut utiliser Melovem<sup>\u00ae<\/sup>\u00a015 mg\/ml ind\u00e9pendamment via l\u2019aliment ou directement dans la bouche du cheval. Le m\u00e9dicament v\u00e9t\u00e9rinaire est soumis \u00e0 prescription.<\/p>\n<p>Vous pouvez utiliser Melovem<sup>\u00ae<\/sup>\u00a015 mg\/ml pour le soulagement de l\u2019inflammation et de la douleur dans les troubles musculo-squelettiques aigus et chroniques chez les chevaux.<\/p>\n<p>Si les sympt\u00f4mes sont s\u00e9v\u00e8res, le v\u00e9t\u00e9rinaire peut d\u2019abord administrer Melovem<sup>\u00ae<\/sup> Administrer 20 mg\/ml par voie intraveineuse. Si un traitement de suivi est souhaitable, il peut \u00eatre effectu\u00e9 avec Melovem<sup>\u00ae<\/sup> Suspension orale de 15 mg\/ml.<\/p>\n<h4>Conditionnement unique pour un b\u00e9n\u00e9fice maximal de Melovem<sup>\u00ae<\/sup> 15 mg\/ml<\/h4>\n<p>Melovem<sup>\u00ae<\/sup>\u00a015 mg\/ml suspension buvable pour chevaux est pr\u00e9sent\u00e9e dans un conditionnement unique. La forme du flacon permet de secouer facilement la suspension. La conception unique garantit \u00e9galement que le produit est pleinement utilis\u00e9 ; pas une goutte n\u2019est gaspill\u00e9e.<\/p>\n<p>De plus, vous trouverez dans l\u2019emballage une seringue assortie avec une graduation en fonction du poids corporel. Le couvercle (r\u00e9utilisable) poss\u00e8de \u00e9galement une graduation. Enfin, les flacons sont con\u00e7us de telle mani\u00e8re qu\u2019ils peuvent \u00eatre empil\u00e9s de plusieurs mani\u00e8res. Tr\u00e8s pratique \u00e0 ranger dans votre pharmacie.<\/p>\n<p><a href=\"https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Melovem-15-mgml-250ml-NL-SAMPLE-ETIKET_cropped.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-7981 aligncenter\" src=\"https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Melovem-15-mgml-250ml-NL-SAMPLE-ETIKET_cropped-300x142.jpg\" alt=\"Melovem 15 mg\/ml photo du produit\" width=\"300\" height=\"142\" srcset=\"https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Melovem-15-mgml-250ml-NL-SAMPLE-ETIKET_cropped-300x142.jpg 300w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Melovem-15-mgml-250ml-NL-SAMPLE-ETIKET_cropped-450x212.jpg 450w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Melovem-15-mgml-250ml-NL-SAMPLE-ETIKET_cropped-18x8.jpg 18w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Melovem-15-mgml-250ml-NL-SAMPLE-ETIKET_cropped.jpg 600w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>Melovem<sup>\u00ae<\/sup>\u00a015 mg\/ml est donc une solution conviviale pour le propri\u00e9taire de chevaux qui fait partie de la bo\u00eete \u00e0 outils de tout v\u00e9t\u00e9rinaire.<\/p>\n<p><a href=\"https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-scaled.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-7980 aligncenter\" src=\"https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-300x132.jpg\" alt=\"Melovem 15 mg\/ml logo\" width=\"300\" height=\"132\" srcset=\"https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-300x132.jpg 300w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-450x198.jpg 450w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-1030x452.jpg 1030w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-768x337.jpg 768w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-1536x674.jpg 1536w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-2048x899.jpg 2048w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-18x8.jpg 18w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-1500x658.jpg 1500w, https:\/\/www.dopharma.be\/wp-content\/uploads\/2023\/08\/Logo-Melovem-bottle-horse-V1_blue-705x309.jpg 705w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><a href=\"https:\/\/www.dopharma.be\/fr\/produit\/melovem-15-mg-ml\/\">Consultez la page du produit pour obtenir des informations compl\u00e8tes sur le produit.<\/a><\/p>\n<p>En savoir plus ? Prenez\u00a0<a href=\"https:\/\/www.dopharma.be\/fr\/contact-2-2\/\">contact<\/a>\u00a0avec nous !<\/p>","protected":false},"excerpt":{"rendered":"<p>Optimale verpakking en eenvoudige toediening: Melovem\u00ae\u00a015 mg\/ml orale suspensie voor pijnverlichting bij paarden Raamsdonksveer 24-08-2023\u00a0\u2013 Dopharma breidt haar NSAID-assortiment uit met Melovem\u00ae\u00a015 mg\/ml. Deze orale suspensie is exclusief voor paard geregistreerd en een welkome toevoeging op de bekende Melovem\u00ae\u00a020 mg\/ml injectie (i.v.) van Dopharma voor de behandeling van paarden. Snelle pijnverlichting dankzij het zelf toedienen [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":2465,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[339,340,341,133],"class_list":["post-7982","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nieuws","tag-melovem","tag-melovem-15-mg-ml","tag-paard","tag-persbericht"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Persbericht | Introductie Melovem\u00ae 15 mg\/ml - Dopharma.BE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dopharma.be\/fr\/nouvelles-2\/communique-de-presse-melovem-15-mg-ml\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Persbericht | Introductie Melovem\u00ae 15 mg\/ml - Dopharma.BE\" \/>\n<meta property=\"og:description\" content=\"Optimale verpakking en eenvoudige toediening: Melovem\u00ae\u00a015 mg\/ml orale suspensie voor pijnverlichting bij paarden Raamsdonksveer 24-08-2023\u00a0\u2013 Dopharma breidt haar NSAID-assortiment uit met Melovem\u00ae\u00a015 mg\/ml. Deze orale suspensie is exclusief voor paard geregistreerd en een welkome toevoeging op de bekende Melovem\u00ae\u00a020 mg\/ml injectie (i.v.) van Dopharma voor de behandeling van paarden. Snelle pijnverlichting dankzij het zelf toedienen [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dopharma.be\/fr\/nouvelles-2\/communique-de-presse-melovem-15-mg-ml\/\" \/>\n<meta property=\"og:site_name\" content=\"Dopharma.BE\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-24T06:14:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-17T09:50:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.dopharma.be\/wp-content\/uploads\/2016\/10\/Iconen-nieuwsitems-7.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Anouk Van der Werf\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anouk Van der Werf\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture est.\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/\"},\"author\":{\"name\":\"Anouk Van der Werf\",\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/fr\\\/#\\\/schema\\\/person\\\/89ade717a9a345fe49ec770d10153193\"},\"headline\":\"Persbericht | Introductie Melovem\u00ae 15 mg\\\/ml\",\"datePublished\":\"2023-08-24T06:14:39+00:00\",\"dateModified\":\"2024-10-17T09:50:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/\"},\"wordCount\":294,\"image\":{\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.dopharma.be\\\/wp-content\\\/uploads\\\/2016\\\/10\\\/Iconen-nieuwsitems-7.png\",\"keywords\":[\"Melovem\",\"Melovem 15 mg\\\/ml\",\"paard\",\"persbericht\"],\"articleSection\":[\"Nieuws\"],\"inLanguage\":\"fr-BE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/\",\"url\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/\",\"name\":\"Persbericht | Introductie Melovem\u00ae 15 mg\\\/ml - Dopharma.BE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.dopharma.be\\\/wp-content\\\/uploads\\\/2016\\\/10\\\/Iconen-nieuwsitems-7.png\",\"datePublished\":\"2023-08-24T06:14:39+00:00\",\"dateModified\":\"2024-10-17T09:50:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/fr\\\/#\\\/schema\\\/person\\\/89ade717a9a345fe49ec770d10153193\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/#breadcrumb\"},\"inLanguage\":\"fr-BE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-BE\",\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.dopharma.be\\\/wp-content\\\/uploads\\\/2016\\\/10\\\/Iconen-nieuwsitems-7.png\",\"contentUrl\":\"https:\\\/\\\/www.dopharma.be\\\/wp-content\\\/uploads\\\/2016\\\/10\\\/Iconen-nieuwsitems-7.png\",\"width\":800,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/nieuws\\\/persbericht-melovem-15-mg-ml\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.dopharma.be\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Persbericht | Introductie Melovem\u00ae 15 mg\\\/ml\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.dopharma.be\\\/fr\\\/\",\"name\":\"Dopharma.BE\",\"description\":\"BE\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.dopharma.be\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-BE\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.dopharma.be\\\/fr\\\/#\\\/schema\\\/person\\\/89ade717a9a345fe49ec770d10153193\",\"name\":\"Anouk Van der Werf\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-BE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd76df3a425dd4329f955e91f70187d1c3fe0fec6cd8f38ea2a05faa64d210d3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd76df3a425dd4329f955e91f70187d1c3fe0fec6cd8f38ea2a05faa64d210d3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd76df3a425dd4329f955e91f70187d1c3fe0fec6cd8f38ea2a05faa64d210d3?s=96&d=mm&r=g\",\"caption\":\"Anouk Van der Werf\"},\"url\":\"https:\\\/\\\/www.dopharma.be\\\/fr\\\/author\\\/anouk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse | Introduction Melovem\u00ae 15 mg\/ml - Dopharma.BE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dopharma.be\/fr\/nouvelles-2\/communique-de-presse-melovem-15-mg-ml\/","og_locale":"fr_FR","og_type":"article","og_title":"Persbericht | Introductie Melovem\u00ae 15 mg\/ml - Dopharma.BE","og_description":"Optimale verpakking en eenvoudige toediening: Melovem\u00ae\u00a015 mg\/ml orale suspensie voor pijnverlichting bij paarden Raamsdonksveer 24-08-2023\u00a0\u2013 Dopharma breidt haar NSAID-assortiment uit met Melovem\u00ae\u00a015 mg\/ml. Deze orale suspensie is exclusief voor paard geregistreerd en een welkome toevoeging op de bekende Melovem\u00ae\u00a020 mg\/ml injectie (i.v.) van Dopharma voor de behandeling van paarden. Snelle pijnverlichting dankzij het zelf toedienen [&hellip;]","og_url":"https:\/\/www.dopharma.be\/fr\/nouvelles-2\/communique-de-presse-melovem-15-mg-ml\/","og_site_name":"Dopharma.BE","article_published_time":"2023-08-24T06:14:39+00:00","article_modified_time":"2024-10-17T09:50:33+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/www.dopharma.be\/wp-content\/uploads\/2016\/10\/Iconen-nieuwsitems-7.png","type":"image\/png"}],"author":"Anouk Van der Werf","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Anouk Van der Werf","Dur\u00e9e de lecture est.":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/#article","isPartOf":{"@id":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/"},"author":{"name":"Anouk Van der Werf","@id":"https:\/\/www.dopharma.be\/fr\/#\/schema\/person\/89ade717a9a345fe49ec770d10153193"},"headline":"Persbericht | Introductie Melovem\u00ae 15 mg\/ml","datePublished":"2023-08-24T06:14:39+00:00","dateModified":"2024-10-17T09:50:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/"},"wordCount":294,"image":{"@id":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dopharma.be\/wp-content\/uploads\/2016\/10\/Iconen-nieuwsitems-7.png","keywords":["Melovem","Melovem 15 mg\/ml","paard","persbericht"],"articleSection":["Nieuws"],"inLanguage":"fr-BE"},{"@type":"WebPage","@id":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/","url":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/","name":"Communiqu\u00e9 de presse | Introduction Melovem\u00ae 15 mg\/ml - Dopharma.BE","isPartOf":{"@id":"https:\/\/www.dopharma.be\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/#primaryimage"},"image":{"@id":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dopharma.be\/wp-content\/uploads\/2016\/10\/Iconen-nieuwsitems-7.png","datePublished":"2023-08-24T06:14:39+00:00","dateModified":"2024-10-17T09:50:33+00:00","author":{"@id":"https:\/\/www.dopharma.be\/fr\/#\/schema\/person\/89ade717a9a345fe49ec770d10153193"},"breadcrumb":{"@id":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/#breadcrumb"},"inLanguage":"fr-BE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/"]}]},{"@type":"ImageObject","inLanguage":"fr-BE","@id":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/#primaryimage","url":"https:\/\/www.dopharma.be\/wp-content\/uploads\/2016\/10\/Iconen-nieuwsitems-7.png","contentUrl":"https:\/\/www.dopharma.be\/wp-content\/uploads\/2016\/10\/Iconen-nieuwsitems-7.png","width":800,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/www.dopharma.be\/nieuws\/persbericht-melovem-15-mg-ml\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.dopharma.be\/home\/"},{"@type":"ListItem","position":2,"name":"Persbericht | Introductie Melovem\u00ae 15 mg\/ml"}]},{"@type":"WebSite","@id":"https:\/\/www.dopharma.be\/fr\/#website","url":"https:\/\/www.dopharma.be\/fr\/","name":"Dopharma.BE","description":"BE","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dopharma.be\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-BE"},{"@type":"Person","@id":"https:\/\/www.dopharma.be\/fr\/#\/schema\/person\/89ade717a9a345fe49ec770d10153193","name":"Anouk Van der Werf","image":{"@type":"ImageObject","inLanguage":"fr-BE","@id":"https:\/\/secure.gravatar.com\/avatar\/fd76df3a425dd4329f955e91f70187d1c3fe0fec6cd8f38ea2a05faa64d210d3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fd76df3a425dd4329f955e91f70187d1c3fe0fec6cd8f38ea2a05faa64d210d3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fd76df3a425dd4329f955e91f70187d1c3fe0fec6cd8f38ea2a05faa64d210d3?s=96&d=mm&r=g","caption":"Anouk Van der Werf"},"url":"https:\/\/www.dopharma.be\/fr\/author\/anouk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/posts\/7982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/comments?post=7982"}],"version-history":[{"count":5,"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/posts\/7982\/revisions"}],"predecessor-version":[{"id":19492,"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/posts\/7982\/revisions\/19492"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/media\/2465"}],"wp:attachment":[{"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/media?parent=7982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/categories?post=7982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dopharma.be\/fr\/wp-json\/wp\/v2\/tags?post=7982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}